Favorable histo-molecular remodeling of pancreatic ductal adenocarcinoma after Total Neoadjuvant Therapy including Stereotactic Body Radiotherapy
C. Bouchart, O. A. Senar, J. Navez, L. Verset, A. Boisson, M. Hein, K. Stosic, E. Quertinmont, V. Tafciu, S. Zhao, L. Mas, N. D'Haene, D. Van Gestel, L. Moretti, I. Rooman, , J.-L. Van Laethem
This study shows that combining FOLFIRINOX with stereotactic body radiotherapy remodels pancreatic ductal adenocarcinoma, improving stromal and metabolic features and prognosis.
bioRxiv · Apr 30, 2024 · PreprintCancer Biology